Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Cancer Res. 2013 Jun 17;73(15):4801–4809. doi: 10.1158/0008-5472.CAN-12-3273

Figure 2.

Figure 2

Kaplan-Meier 2-year survival curves for advanced NSCLC patients grouped by low (solid line) and high (dashed line) expression of serum miR-16 (A), and high (solid line) and low (dashed line) risk scores (B). N = number of patients with an event (death) at 2 years / total number of patients in the dataset. MST=median survival time.